Cargando…
PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
Emerging strategies that center upon the mammalian target of rapamycin (mTOR) signaling for neurodegenerative disorders may bring effective treatment for a number of difficult disease entities. Here we show that erythropoietin (EPO), a novel agent for nervous system disorders, prevents apoptotic SH-...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445503/ https://www.ncbi.nlm.nih.gov/pubmed/23029019 http://dx.doi.org/10.1371/journal.pone.0045456 |